scispace - formally typeset
Open AccessJournal ArticleDOI

From tumor cell metabolism to tumor immune escape.

Reads0
Chats0
TLDR
Evidence on the role of tumor cell metabolism on tumor immune escape open the possibility of combining drugs designed to control tumor cell metabolic with new procedures of anti-tumor immunotherapy.
About
This article is published in The International Journal of Biochemistry & Cell Biology.The article was published on 2013-01-01 and is currently open access. It has received 79 citations till now. The article focuses on the topics: Acquired immune system & Immune system.

read more

Citations
More filters
Journal ArticleDOI

Broad targeting of angiogenesis for cancer prevention and therapy

TL;DR: 10 important aspects of tumor angiogenesis and the pathological tumor vasculature which would be well suited as targets for anti-angiogenic therapy are identified and 10 plant-derived compounds could be combined to constitute a broader acting and more effective inhibitory cocktail at doses that would not be likely to cause excessive toxicity.
Journal ArticleDOI

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?

TL;DR: It is proposed that the maintenance by cancers of a relatively low pH in their micro‐environment, via regulation of their lactic acid secretion through selective modification of their energy metabolism, is another major mechanism by which cancers can suppress the anti‐cancer immune response.
Journal ArticleDOI

The Warburg effect and drug resistance

TL;DR: Details of the current understanding of the complex interplay between glucose metabolism and pharmacology are provided and opportunities for utilizing the Warburg effect in future drug development are discussed.
Journal ArticleDOI

Causes of genome instability: the effect of low dose chemical exposures in modern society

TL;DR: The purpose of this review is to describe the crucial aspects of genome instability, to outline the ways in which environmental chemicals can affect this cancer hallmark and to identify candidate chemicals for further study.
Journal ArticleDOI

Cancer stem cell metabolism: a potential target for cancer therapy.

TL;DR: This review describes the key metabolic pathways required by CSCs to maintain a survival advantage and highlights how a combined approach of targeting cellular metabolism in conjunction with the use of chemotherapeutic drugs may provide a promising strategy to overcome therapeutic resistance and therefore aid in cancer therapy.
References
More filters
Journal ArticleDOI

Myeloid-derived suppressor cells as regulators of the immune system.

TL;DR: The origin, mechanisms of expansion and suppressive functions of MDSCs, as well as the potential to target these cells for therapeutic benefit are discussed.
Journal ArticleDOI

Cancer immunoediting: from immunosurveillance to tumor escape.

TL;DR: The historical and experimental basis of cancer immunoediting is summarized and its dual roles in promoting host protection against cancer and facilitating tumor escape from immune destruction are discussed.
Journal ArticleDOI

Functions of natural killer cells

TL;DR: Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.
Journal ArticleDOI

Coordinated regulation of myeloid cells by tumours

TL;DR: This work considers myeloid cells as an intricately connected, complex, single system and focuses on how tumours manipulate the myeloids system to evade the host immune response.
Journal ArticleDOI

IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity

TL;DR: It is shown that lymphocytes and IFNγ collaborate to protect against development of carcinogen-induced sarcomas and spontaneous epithelial carcinomas and also to select for tumour cells with reduced immunogenicity, which explains the apparent paradox of tumour formation in immunologically intact individuals.
Related Papers (5)
Frequently Asked Questions (19)
Q1. What is the effect of DCA on tumor cells?

It is believed that by inducing a metabolic change from fermentation to OXPHOS, DCA specifically induces apoptosis in tumor cells. 

They metabolize L-arginine with the enzymes arginase and nitric oxide synthase (NOS) generating products that inhibit the function of infiltrating lymphocytes and, in addition, depriving lymphocytes of arginine. 

Villalba et al. this paper suggested that changes in tumor cell metabolism may propel tumor cell immune escape. 

miRNAs play a central role in regulating posttranscriptional gene expression by annealing to the 3‟ untranslated regions of target mRNAs to generally promote mRNA degradation or translational repression (Chhabra et al., 2010). 

cells growing in glutamine increase p65 translocation to the nucleus where it controls glutamine metabolism by downregulating miR-23a levels. 

In addition, LXRs are also implicated in PNT formation and therefore can affect T cell activation as described above (Russo, 2011). 

in absence of ATP-citrate lyase, which ensures the production of acetyl-CoA from citrate, global histone acetylation is reduced. 

fermentation is much quicker than respiration on producing ATP and offers a selective advantage to rapidly growing tumor cells. 

In summary, the Warburg effect, which is currently called aerobic glycolysis because of the increase rate of glycolysis in the presence of oxygen, is not the only feature of tumor cell metabolism. 

a certain quantity of pyruvate, the main “fuel” used by mitochondria, still enters the tricarboxylic acid (TCA) cycle for bioenergetic and biosynthetic purposes (Levine and Puzio-Kuter, 2010). 

DCA inhibits pyruvate dehydrogenase kinase isozyme 1 (PDK1; (Whitehouse et al., 1974) and, therefore, activates pyruvate dehydrogenase isozyme 1 (PDH1; (Bartrons and Caro, 2007). 

The results suggest that GTN has a consistent, inhibitory effect on prostate-specific antigen (PSA)-expressing tumor progression in men with recurrent prostate cancer after primary treatment failure. 

tumor metabolic shift is probably due to several processes including overexpression of glycolytic enzymes and metabolite transporters, defects in cellular respiration and oncogenic alterations. 

a clinical benefit is observed in a low number of patients, probably because tumors produce some immunomodulators that block CTL activity (see above). 

The expression of one or more of these proteins is often altered in tumor cells, leading to a decrease of surface expression of MHC-I. 

This is a general overview because some adhesion molecules, such as like mucin-1 (MUC1), are usually overexpressed in tumors and functions as a TAA (Pashov et al., 2010). 

More than this, because cellular lactate secretion via monocarboxylate transporters (MCTs) is accompanied by H + transport, a decrease in extracellular pH results in a reduction of CTL function due to intracellular accumulation of lactate (Fischer et al., 2007,Dietl et al., 2010). 

tumor cell metabolism is most likely linked to tumor cell development because several waves of gene regulation constantly modify the metabolism during tumorigenesis (Smolkova et al., 2011). 

this cholesterol efflux was not observed when engulfed cells trigger inflammatory signaling (i.e. Fc Receptor engagement or necrosis sensing) suggesting that cholesterol load may depend on inflammatory condition encountered by the phagocytes.